Cargando…

P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME

Detalles Bibliográficos
Autores principales: Castells, M., Scherber, R., Bhavsar, V., He, K., Akin, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430067/
http://dx.doi.org/10.1097/01.HS9.0000846936.51452.f2
_version_ 1784779645460152320
author Castells, M.
Scherber, R.
Bhavsar, V.
He, K.
Akin, C.
author_facet Castells, M.
Scherber, R.
Bhavsar, V.
He, K.
Akin, C.
author_sort Castells, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9430067
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94300672022-08-31 P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME Castells, M. Scherber, R. Bhavsar, V. He, K. Akin, C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430067/ http://dx.doi.org/10.1097/01.HS9.0000846936.51452.f2 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Castells, M.
Scherber, R.
Bhavsar, V.
He, K.
Akin, C.
P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
title P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
title_full P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
title_fullStr P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
title_full_unstemmed P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
title_short P1017: HARBOR: A PHASE 2/3 STUDY OF BLU-263 IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AND MONOCLONAL MAST CELL ACTIVATION SYNDROME
title_sort p1017: harbor: a phase 2/3 study of blu-263 in patients with indolent systemic mastocytosis and monoclonal mast cell activation syndrome
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430067/
http://dx.doi.org/10.1097/01.HS9.0000846936.51452.f2
work_keys_str_mv AT castellsm p1017harboraphase23studyofblu263inpatientswithindolentsystemicmastocytosisandmonoclonalmastcellactivationsyndrome
AT scherberr p1017harboraphase23studyofblu263inpatientswithindolentsystemicmastocytosisandmonoclonalmastcellactivationsyndrome
AT bhavsarv p1017harboraphase23studyofblu263inpatientswithindolentsystemicmastocytosisandmonoclonalmastcellactivationsyndrome
AT hek p1017harboraphase23studyofblu263inpatientswithindolentsystemicmastocytosisandmonoclonalmastcellactivationsyndrome
AT akinc p1017harboraphase23studyofblu263inpatientswithindolentsystemicmastocytosisandmonoclonalmastcellactivationsyndrome